Qiang Chang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Qiang Chang has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Ying Zhao
Department of Plastic and Reconstruction Surgery, Southern Medical University Nanfang Hospital, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, Guangdong, 510515, China, Guangzhou, Guangdong, 510515, CHINA
2 shared publicationsChenlu Wu
Department of Plastic and Reconstruction Surgery, Southern Medical University Nanfang Hospital, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, Guangdong Province, 510515, China, Guangzhou, Guangdong, 510515, CHINA
1 shared publicationDan Sun
Department of Plastic and Reconstruction Surgery, Southern Medical University Nanfang Hospital, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, Guangdong Province, 510515, China, Guangzhou, Guangdong, 510515, CHINA
1 shared publicationFeng Lu
Department of Plastic and Reconstruction Surgery, Southern Medical University Nanfang Hospital, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, Guangdong Province, 510515, China, Guangzhou, Guangdong, 510515, CHINA
1 shared publication- Qiang Chang
Department of Plastic and Reconstruction Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China
1 shared publication Ting Li
Department of Oncology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, 415003, China
1 shared publication
Latest Publications
- Open Access
- 1 July 2025
- Published by IOP Publishing in Biofabrication
- Vol. 17 (3) , 035024
A photosynthetic egg based oxygen-releasing platform to promote angiogenesis and tissue regeneration in diabetic wounds
Diabetic wounds represent a longstanding global health challenge attributable to tissue hypoxia resulting from impaired microcirculation, which impedes crucial physiological processes essential for wound healing, such as cell proliferation and migration. Oxygen-releasing biomaterials present a novel avenue for tissue reoxygenation therapy, offering advantages over conventional hyperbaric oxygen therapy. Herein, we developed a microcosmic oxygen-releasing platform (MORP) named photosynthetic egg by utilizing egg white hydrogel with inherent bioactive factors for regenerative strength and electrostatic adsorbed Chlorella bringing photosynthetic oxygen production. The dissolved oxygen concentration leaped to more than 10 mg l−1 under hypoxic conditions through manipulating supplemental dosage and illumination intensity demonstrating high flexibility and controllability of MORP. In vitro experiments, coupled with transcriptome sequencing and quantitative real-time polymerase chain reaction analysis, demonstrated that MORP significantly augmented cell proliferation, migration, and angiogenesis, serving as a rejuvenating agent to alleviate DNA damage and cellular dysfunction in hypoxic environments. Further in vivo investigations substantiated that MORP expedited diabetic wound healing by fostering tissue regeneration, collagen deposition, and angiogenesis owing to its bioactive constituents and reoxygenation capabilities. These findings underscore the potential therapeutic efficacy of MORP as an innovative approach for managing diabetic wounds.
- 1 July 2025
- Published by IOP Publishing in Biofabrication
- Vol. 17 (3) , 035024
Open AccessA photosynthetic egg based oxygen-releasing platform to promote angiogenesis and tissue regeneration in diabetic wounds
Diabetic wounds represent a longstanding global health challenge attributable to tissue hypoxia resulting from impaired microcirculation, which impedes crucial physiological processes essential for wound healing, such as cell proliferation and migration. Oxygen-releasing biomaterials present a novel avenue for tissue reoxygenation therapy, offering advantages over conventional hyperbaric oxygen therapy. Herein, we developed a microcosmic oxygen-releasing platform (MORP) named photosynthetic egg by utilizing egg white hydrogel with inherent bioactive factors for regenerative strength and electrostatic adsorbed Chlorella bringing photosynthetic oxygen production. The dissolved oxygen concentration leaped to more than 10 mg l−1 under hypoxic conditions through manipulating supplemental dosage and illumination intensity demonstrating high flexibility and controllability of MORP. In vitro experiments, coupled with transcriptome sequencing and quantitative real-time polymerase chain reaction analysis, demonstrated that MORP significantly augmented cell proliferation, migration, and angiogenesis, serving as a rejuvenating agent to alleviate DNA damage and cellular dysfunction in hypoxic environments. Further in vivo investigations substantiated that MORP expedited diabetic wound healing by fostering tissue regeneration, collagen deposition, and angiogenesis owing to its bioactive constituents and reoxygenation capabilities. These findings underscore the potential therapeutic efficacy of MORP as an innovative approach for managing diabetic wounds.
- 5 June 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 13 (28) , 8470-8482
Synergistic integration of ADSCs and egg white hydrogel microspheres for accelerated wound regeneration
Accelerating wound healing poses a significant challenge in clinical practice, necessitating the exploration of innovative strategies. The development of biomaterials with tissue repair and regenerative properties represents a forefront approach to addressing this challenge; however, the functional characteristics and application methods of these materials remain limited. In this context, a novel bioactive micro carrier (Bio-MC) was developed from egg white hydrogel microspheres (EWMs) which served as a bio-niche incorporating adipose-derived stem cells (ADSCs). This formulation capitalizes on the intrinsic tissue reparative capabilities of stem cells, allowing for the sustained release of multiple growth factors. These factors, via paracrine signaling, promote the proliferation and migration of neighboring cells, thereby creating an environment that supports wound healing. Upon application to wound sites, Bio-MCs exhibited significant effectiveness in enhancing the healing process by promoting tissue regeneration, increasing collagen deposition, and facilitating vascularization. The paracrine signaling mediated by Bio-MCs has the potential to exert lasting beneficial effects on cells in a comprehensive and physiologically relevant manner. In comparison to conventional growth factor treatments, the Bio-MC offers enhanced application versatility and functional attributes, indicating substantial promise in the field of tissue repair and regeneration and representing a noteworthy advancement in the clinical management of wounds.
- 5 June 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 13 (28) , 8470-8482
Synergistic integration of ADSCs and egg white hydrogel microspheres for accelerated wound regeneration
Accelerating wound healing poses a significant challenge in clinical practice, necessitating the exploration of innovative strategies. The development of biomaterials with tissue repair and regenerative properties represents a forefront approach to addressing this challenge; however, the functional characteristics and application methods of these materials remain limited. In this context, a novel bioactive micro carrier (Bio-MC) was developed from egg white hydrogel microspheres (EWMs) which served as a bio-niche incorporating adipose-derived stem cells (ADSCs). This formulation capitalizes on the intrinsic tissue reparative capabilities of stem cells, allowing for the sustained release of multiple growth factors. These factors, via paracrine signaling, promote the proliferation and migration of neighboring cells, thereby creating an environment that supports wound healing. Upon application to wound sites, Bio-MCs exhibited significant effectiveness in enhancing the healing process by promoting tissue regeneration, increasing collagen deposition, and facilitating vascularization. The paracrine signaling mediated by Bio-MCs has the potential to exert lasting beneficial effects on cells in a comprehensive and physiologically relevant manner. In comparison to conventional growth factor treatments, the Bio-MC offers enhanced application versatility and functional attributes, indicating substantial promise in the field of tissue repair and regeneration and representing a noteworthy advancement in the clinical management of wounds.